Dr. Reddy's Laboratories Limited
PPFAS Mutual Fund trimmed its stake in Dr. Reddy's Laboratories Limited, selling 24,81,739 shares to reduce its holding from 1.47 Cr shares to 1.22 Cr shares, representing 1.46% of the company.
A leading India-based pharmaceutical company, Dr Reddy's Laboratories manufactures and distributes Active Pharmaceutical Ingredients, generic medicines, biosimilars, and differentiated formulations across multiple therapeutic areas. The company operates custom pharmaceutical services and serves patients in markets worldwide. Its integrated operations span drug discovery, development, manufacturing, and commercialization of innovative and generic pharmaceuticals for diverse healthcare needs.
Founded by Parag Parikh Financial Advisory Services, best known for the Parag Parikh Flexi Cap Fund which invests in both Indian equities and select global large-caps including Meta, Alphabet, and Microsoft. Manages over Rs 1.2 lakh crore with a concentrated, long-duration, value-focused approach. CIO Rajeev Thakkar is one of India's most respected investors with a Munger-influenced thinking style.